Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells

An emerging role for TOR signaling in mammalian tissue and stem cell physiology

(2011) Ryan C. Russell et al.   DEVELOPMENT

TOR kinase complexes and cell migration

(2011) Lunhua Liu et al.   JOURNAL OF CELL BIOLOGY

Genetic variation in insulin/IGF-1 signaling pathways and longevity

(2010) Elad Ziv et al.   AGEING RESEARCH REVIEWS

Older men with low serum IGF-1 have an increased risk of incident fractures: The MrOS Sweden study

(2010) Claes Ohlsson et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Skeletal sexual dimorphism: relative contribution of sex steroids, GH–IGF1, and mechanical loading

(2010) Filip Callewaert et al.   JOURNAL OF ENDOCRINOLOGY

Maximizing bone mineral mass gain during growth for the prevention of fractures in the adolescents and the elderly

(2009) René Rizzoli et al.   BONE

Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease

(2009) Antonino Belfiore et al.   ENDOCRINE REVIEWS

The Role of Liver-Derived Insulin-Like Growth Factor-I

(2009) Claes Ohlsson et al.   ENDOCRINE REVIEWS

TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation

(2009) Yi Tang et al.   NATURE MEDICINE

Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span

(2009) C. Selman et al.   SCIENCE

Growth Hormone, Insulin-Like Growth Factors, and the Skeleton

(2008) Andrea Giustina et al.   ENDOCRINE REVIEWS

IGF-1 as an early marker for low bone mass or osteoporosis in premenopausal and postmenopausal women

(2008) Jian-min Liu et al.   JOURNAL OF BONE AND MINERAL METABOLISM